Edition #179
Investing Unlocks: How to Read the Hot Topics From The Last 7 Days
News, earnings, analyst moves and one chart worth your time.
š·ļø Hot Inflation Cools the AI Rally
Last week, hotter than expected inflation and worries about how AI companies pay for their spending knocked tech off its perch. Consumer prices rose 3.7% from a year ago and wholesale prices jumped far more than forecast, lifting bets on another Fed rate hike and pushing the 10-year Treasury yield above 5%. Chipmakers took the biggest hit as investors questioned data center deals funded by debt, while money rotated into health care and financials, helping the Dow outperform. Big banks kicked off earnings season on a mixed note, with strong trading results at some lenders offset by misses at others.
This week, earnings take center stage with Netflix, Tesla, Meta and IBM reporting, giving investors a fresh read on whether heavy AI spending is paying off. Bond yields remain the key risk ahead of the Fedās late October meeting, since a 10-year yield above 5% makes safer assets more appealing and weighs on pricey growth stocks, while housing data and early factory and service surveys round out a lighter economic calendar. Strong results could steady tech, but last weekās rotation is a reminder that spreading money across sectors helps cushion these swings.
Hot Topics
Morgan Stanleyās Robot Swarm Vision for SpaceX
If Morgan Stanley is right, investors could be valuing SpaceX as a rocket and satellite company when it may become one of the worldās biggest AI computing networks, but for now it is spending about six dollars on AI for every dollar it earns back.
CoreWeave Bond Slump Shows AIās Growing Debt Problem
AI data centers are being built on riskier debt than people realized. For investors, rising borrowing costs and construction delays could squeeze profits, increase default risks and weigh on valuations across AI infrastructure stocks.Bumble Takeover
Bumbleās $1.3 billion takeover highlights the potential for significant gains in beaten-down tech stocks while raising the prospect of further consolidation in the struggling online dating industry.Wholesale inflation just had its worst month since 2022
September producer prices rose 1.3% on the month and 6.3% over the year, both the biggest jumps in roughly four years, driven mostly by energy costs. This matters because it clouds the picture ahead of the Fedās October 27 to 28 meeting and could keep borrowing costs higher for longer.
Apple Locks In $5 Trillion
Apple closed Wednesday at $342.96, valuing the company at about $5.01 trillion. That makes it only the second company ever to end a trading day above $5 trillion, after Nvidia. Apple first poked above the line during trading in July and has crossed it several times since, but this was the first time it held through the closing bell. Solid iPhone demand and a more careful approach to AI spending than its Big Tech rivals have made Apple look like a steadier way to own the tech boom.
The bigger issue is what this means for index funds. In mid-October, Nvidia, Apple and Microsoft made up about 21.4% of the largest S&P 500 tracker fund, according to State Street. Apple alone was about 7.5%, so a 10% drop in its shares would pull the whole index down roughly 0.75% on its own. Many investors who think they own 500 companies are making a big bet on three. Apple also faces rising memory chip costs and a new CEO, John Ternus, still settling in. It has already slipped back below $5 trillion, so watch whether that top-three share keeps rising.
Earnings Performance
Johnson & Johnson (NYSE: JNJ)
Johnson & Johnson (NYSE: JNJ) reported its Q3, 2026 earnings. Its stock initially dropped as its medical device sales disappointed analysts, marking the second consecutive quarterly miss for its MedTech division. International MedTech sales have been weighed down by the Middle East conflict, European austerity measures and pricing pressures in China. J&J raised its full-year revenue guidance to approximately $101.2 billion at the midpoint, up from $101.1 billion.
Other Earnings Updates
Reporting this week: Netflix, Tesla, GM, RTX, Coca-Cola, IBM, Texas Instruments, Procter & Gamble, McDonaldās, Intel, Chevron, American Express and ExxonMobil.
Upgrades and Downgrades š
The rating changes that caught our eye this week, and why the analysts moved.
Analyst ratings are opinions, not recommendations. Always do your own research.
Healthcare AIās Real Test
Healthcare could be where AI starts proving its worth beyond the tech sector. The industry is huge, inefficient and facing rising demand from aging populations. The bigger prize may not be finding the next blockbuster drug but avoiding the billions spent on ones that fail. The early numbers are encouraging. A 2024 study found AI-discovered molecules pass first-stage safety trials 80% to 90% of the time, against a historical average of roughly 40% to 65%. Combine defensive demand with long-term growth and the case looks compelling.
The catch is in the next stage. When trials test whether a drug actually works, AI-found molecules succeed about 40% of the time, roughly the industry norm. No AI-discovered drug has yet won approval, and the first fully AI-designed one only reached late-stage trials in July. Todayās trial results are really a report card on AI from several years ago, since drugs take years to reach patients. Prediction tools also learn mostly from published successes, since failed trials often go unreported, which can make them overconfident. The paperwork promise faces a similar problem. AI can draft clinical notes, but every word still needs a clinician to check it, and more output can mean more reading. Watch for companies reporting hard numbers on costs and time saved, not just AI ambitions.